Free Cash Flow for Boston Scientific (BSX)
Free Cash Flow for Boston Scientific (BSX): headline value $3.63B · YoY +38.3%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingFree Cash FlowSwitch metric
Latest period
$3.63B
YoY change
+38.3%
5Y CAGR
+26.4%
Peak year (2025)
$3.66B
Latest annual
$3.66B
Free Cash Flow history chart for Boston Scientific (BSX) from 1991 to 2025
Free Cash Flow history table for Boston Scientific (BSX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Free Cash Flow | YoY |
|---|---|---|---|---|
| 2025 | $3.66B | +38.3% | ||
| 2024 | $2.65B | +55.3% | ||
| 2023 | $1.70B | +86.3% | ||
| 2022 | $914.00M | -30.5% | ||
| 2021 | $1.32B | +16.3% | ||
| 2020 | $1.13B | -17.7% | ||
| 2019 | $1.38B | -23016.7% | ||
| 2018 | -$6.00M | -100.5% | ||
| 2017 | $1.11B | +85.7% | ||
| 2016 | $596.00M | +68.8% | ||
| 2015 | $353.00M | -65.0% | ||
| 2014 | $1.01B | +20.7% | ||
| 2013 | $837.00M | -19.1% | ||
| 2012 | $1.03B | +46.9% | ||
| 2011 | $704.00M | +1397.9% | ||
| 2010 | $47.00M | -90.1% | ||
| 2009 | $473.00M | -44.6% | ||
| 2008 | $854.00M | +49.6% | ||
| 2007 | $571.00M | -62.0% | ||
| 2006 | $1.50B | +167.6% | ||
| 2005 | $562.00M | -63.3% | ||
| 2004 | $1.53B | +155.4% | ||
| 2003 | $599.00M | -4.0% | ||
| 2002 | $624.00M | +69.1% | ||
| 2001 | $369.00M | -44.3% | ||
| 2000 | $663.00M | +2.5% | ||
| 1999 | $647.00M | -132.8% | ||
| 1998 | -$1.98B | +1152.7% | ||
| 1997 | -$157.70M | +15670.0% | ||
| 1996 | -$1.00M | -97.7% | ||
| 1995 | -$44.00M | -237.5% | ||
| 1994 | $32.00M | +6.7% | ||
| 1993 | $30.00M | -6.5% | ||
| 1992 | $32.10M | +43.9% | ||
| 1991 | $22.30M | — |
Free Cash Flow values are taken from Boston Scientific's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Boston Scientific (BSX) most recent annual free cash flow stands at $3.66B (2025) – surged 38.3% year-over-year.
Over 2020–2025 (5 years), Boston Scientific free cash flow expanded at a +26.4% compound annual rate, sustaining 3 straight years of year-over-year growth.
Across the available history, free cash flow reached its high of $3.66B in 2025 and its low of -$1.98B in 1998.
Within Healthcare, Boston Scientific (BSX) ranks 9th among 8 peers we track. The peer median for free cash flow is $14.22B.
Boston Scientific Free Cash Flow by Year
Boston Scientific Free Cash Flow 2025: $3.66B
Boston Scientific free cash flow in 2025 was $3.66B, surged 38.3% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Free Cash Flow 2024: $2.65B
Boston Scientific free cash flow in 2024 was $2.65B, surged 55.3% from 2023.
Boston Scientific Free Cash Flow 2023: $1.70B
Boston Scientific free cash flow in 2023 was $1.70B, surged 86.3% from 2022.
Boston Scientific Free Cash Flow 2022: $914.00M
Boston Scientific free cash flow in 2022 was $914.00M, plunged 30.5% below 2021.
Boston Scientific Free Cash Flow 2021: $1.32B
Boston Scientific free cash flow in 2021 was $1.32B.
See more financial history for Boston Scientific (BSX).
Sector peers — Free Cash Flow
Companies in the same sector as Boston Scientific, ranked by their latest free cash flow.
| Company | Free Cash Flow | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $28.99B | Healthcare |
| Johnson & Johnson (JNJ) | $19.70B | Healthcare |
| AbbVie Inc. (ABBV) | $17.82B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $16.07B | Healthcare |
| Merck & Co., Inc. (MRK) | $12.36B | Healthcare |
| AstraZeneca PLC (AZN) | $11.77B | Healthcare |
| Eli Lilly and Company (LLY) | $8.97B | Healthcare |
| Amgen Inc. (AMGN) | $8.10B | Healthcare |
Frequently asked questions
What is Boston Scientific's free cash flow?
Latest reported free cash flow for Boston Scientific (BSX) is $3.63B (period ending December 31, 2025).
How has Boston Scientific free cash flow changed year-over-year?
Boston Scientific (BSX) free cash flow changed +38.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Boston Scientific free cash flow?
Boston Scientific (BSX) free cash flow compound annual growth rate is +26.4% over the most recent 5 years available.
When did Boston Scientific free cash flow hit its highest annual value?
Boston Scientific free cash flow reached its highest annual value of $3.66B in 2025.
What was Boston Scientific free cash flow in 2024?
Boston Scientific (BSX) free cash flow in 2024 was $2.65B.
What was Boston Scientific free cash flow in 2025?
Boston Scientific (BSX) free cash flow in 2025 was $3.66B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
BSX Overview
Company profile, financial tools, and key metrics
BSX Revenue Counter
Earns $653.70 every second. See per minute, hour, and day.
BSX Earnings Counter
Earns $112.66 per second net profit. See per minute, hour, and day.
BSX Economic Scale
Exceeds Niger's GDP. Compare with world economies.
BSX What If Invested
What if you had invested $1,000? See historical returns from any date.
BSX How It Makes Money
Discover visual breakdown of $20.61B in revenue — where it comes from and where it goes.
BSX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BSX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BSX Daily Price Character
Balanced · 48.8% historical win rate (green days). Streaks & record days.
BSX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BSX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.